Horiba for Healthcare

Horiba for Healthcare Proven quality and trustworthy performance have established widespread confidence in the HORIBA brand.

HORIBA provides an extensive and comprehensive line of hematology, hemostasis, and clinical chemistry solutions (including analyzers, reagents, and consumables) for use in in vitro diagnostics. Today, more than 30,000 laboratories are using HORIBA’s healthcare solutions around the world.

 This year's theme focuses on "Diabetes and the workplace," emphasizing the importance of workplace access to diagnostic...
14/11/2025


This year's theme focuses on "Diabetes and the workplace," emphasizing the importance of workplace access to diagnostic tools and care.

With timely and accurate testing, individuals living with diabetes can take control of their wellbeing and live healthier, more empowered lives.

At HORIBA, we are committed to supporting clinics and laboratories through reliable diagnostic solutions that help improve diabetes management.

Monitoring remains a cornerstone measurement in diabetes care. Its ability to reflect the patient's average blood glucose over the prior 2-3 months makes it essential for diagnosis, therapy optimization, and tracking long-term risk. (More about HbA1c: https://bit.ly/4nHBfGy) HORIBA POINTE HbA1c, and reagent portfolio is designed for:
- High accuracy & reproducibility
- Optimized workflow integration
- Streamlined QC + cost-effectiveness

When paired with HORIBA chemistry systems, these reagents help laboratories deliver consistent data that support better clinical decisions-wherever care begins.

Together, we can empower organizations and their teams with the insights they need to build healthier workplaces.

HORIBA – Pioneer of CBC + CRP analyzers with 20+ years of expertise and trusted innovation in infection diagnostics.​Dri...
13/11/2025

HORIBA – Pioneer of CBC + CRP analyzers with 20+ years of expertise and trusted innovation in infection diagnostics.​

Driven by the voice of healthcare professionals, HORIBA developed simultaneous CBC + CRP testing—responding to the need for faster, more comprehensive infection screening. From our first analyzer to today’s advanced solutions, we continue to evolve with clinical needs.

Innovation Meets Collaboration at HORIBA Kyoto💡We were thrilled to welcome Professor Catherine Alix-Panabières from the ...
12/11/2025

Innovation Meets Collaboration at HORIBA Kyoto💡We were thrilled to welcome Professor Catherine Alix-Panabières from the University of Montpellier for an inspiring day dedicated to Liquid Biopsy: The Journey of a Medical Revolution. From insightful lectures to hands-on workshops and discussions on future projects, this event showcased the power of partnership in advancing oncology research.

Together, we’re shaping the future of cancer diagnostics.

It's quiz time with  ! A female presents with the following results. The blood smear is Microcytic/Hypochromic, Target C...
10/11/2025

It's quiz time with ! A female presents with the following results. The blood smear is Microcytic/Hypochromic, Target Cell, poikilocytosis. Which 2 additional tests should be performed?

a) Iron status
b) Hemoglobin analysis
c) Haptoglobin
d) Liver Function tests
e) Clotting screen

Share your thoughts in the comments and wait for answers next week!

Deep dive into the world of hematology with our newsletter , spotlighting morphology case studies, slide reviews, advances in technology, and exploring blood disorders. 👉 https://bit.ly/4olEnJv

🦟 Malaria still claims over 600,000 lives annually, with children being the most affected. Despite global efforts, early...
06/11/2025

🦟 Malaria still claims over 600,000 lives annually, with children being the most affected. Despite global efforts, early and accurate diagnosis remains a challenge.​

At HORIBA, we’re committed to advancing innovation in infection management—making diagnostics smarter, faster, and more accessible.​

A new chapter in HORIBA’s malaria screening solutions is on the horizon.​

Follow us and stay tuned.

Welcome to the 5th edition of our hematology newsletter  !Explore our latest newsletter featuring:▪️ 𝐌𝐨𝐫𝐩𝐡𝐨𝐥𝐨𝐠𝐲 𝐂𝐚𝐬𝐞 𝐒𝐭𝐮...
03/11/2025

Welcome to the 5th edition of our hematology newsletter !

Explore our latest newsletter featuring:
▪️ 𝐌𝐨𝐫𝐩𝐡𝐨𝐥𝐨𝐠𝐲 𝐂𝐚𝐬𝐞 𝐒𝐭𝐮𝐝𝐲
Discover how a preliminary diagnosis of Acute Myeloid Leukemia ( ) was made after a general practitioner visit for symptoms of shortness of breath and fatigue. Learn how AML can present in blood test findings and which additional investigations are recommended for confirmation.

▪️ 𝐁𝐚𝐬𝐨𝐩𝐡𝐢𝐥𝐬
Learn about — how they are produced in the bone marrow, their role in the immune system, and their function in allergic responses and inflammation.

Read on the website, find back issues, and subscribe: https://bit.ly/43dHTwZ

The next issue of  , HORIBA’s 𝐡𝐞𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫, is arriving in early November—and you won’t want to miss it!Whether...
31/10/2025

The next issue of , HORIBA’s 𝐡𝐞𝐦𝐚𝐭𝐨𝐥𝐨𝐠𝐲 𝐧𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫, is arriving in early November—and you won’t want to miss it!

Whether you're in clinical diagnostics, laboratory management, or hematology research—or just beginning your journey in the field—HemeInsights delivers expert perspectives, real-world case studies, and technology updates tailored to your needs.

📬 Subscribe now to receive the next issue directly in your inbox: https://bit.ly/3PKIRJ2

📚 Explore past issues here: https://bit.ly/3Jzf6fJ

Antimicrobial resistance (AMR) is a growing global threat—one that demands smarter diagnostics. We're advancing the inno...
30/10/2025

Antimicrobial resistance (AMR) is a growing global threat—one that demands smarter diagnostics. We're advancing the innovation to bring more value to infection management.

Follow us and stay tuned for an evolution in HORIBA's simultaneous CBC and CRP measurement solution.​

We’re pleased to share a recent contribution to veterinary diagnostics. HORIBA Brazil, in collaboration with Hospital Ve...
29/10/2025

We’re pleased to share a recent contribution to veterinary diagnostics. HORIBA Brazil, in collaboration with Hospital Veterinário Cães e Gatos and Transfucão – Banco de Sangue e Hemoterapia Veterinária (Veterinary Hospital for Dogs and Cats and Transfusion – Blood Bank and Veterinary Hemotherapy), published the study “𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐕𝐚𝐥𝐮𝐞𝐬 𝐟𝐨𝐫 𝐂𝐨𝐚𝐠𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐏𝐚𝐫𝐚𝐦𝐞𝐭𝐞𝐫𝐬 𝐢𝐧 𝐂𝐚𝐧𝐢𝐧𝐞 𝐚𝐧𝐝 𝐅𝐞𝐥𝐢𝐧𝐞 𝐒𝐩𝐞𝐜𝐢𝐞𝐬 𝐀𝐬𝐬𝐞𝐬𝐬𝐞𝐝 𝐛𝐲 𝐭𝐡𝐞 𝐇𝐎𝐑𝐈𝐁𝐀 𝐘𝐮𝐦𝐢𝐳𝐞𝐧 𝐆200: 𝐀 𝐓𝐨𝐨𝐥 𝐟𝐨𝐫 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐈𝐧𝐭𝐞𝐫𝐩𝐫𝐞𝐭𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐕𝐞𝐭𝐞𝐫𝐢𝐧𝐚𝐫𝐲 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞.”

The study supports improved diagnostic accuracy by establishing reference values for coagulation parameters in dogs and cats using the 𝐘𝐮𝐦𝐢𝐳𝐞𝐧 𝐆200 𝐚𝐧𝐚𝐥𝐲𝐳𝐞𝐫 and HORIBA-branded reagents. It involved 140 clinically healthy dogs and 44 cats, assessing prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen concentration (FIB).

The results demonstrated the effectiveness of the Yumizen G200 in veterinary hemostatic evaluation, providing veterinarians with an essential tool for accurate diagnosis of coagulopathies - conditions frequently associated with thrombocytopenia, DIC, and intoxications in dogs, as well as hepatic disorders and FIP in cats.

Access the complete study at: https://www.scirp.org/journal/paperinformation?paperid=145693

On October 1st, HORIBA USA attended the 𝐀𝐒𝐂𝐏 𝐖𝐞𝐬𝐭 𝐕𝐢𝐫𝐠𝐢𝐧𝐢𝐚 𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝐌𝐞𝐞𝐭𝐢𝐧𝐠! We truly enjoyed meeting with laboratory pro...
28/10/2025

On October 1st, HORIBA USA attended the 𝐀𝐒𝐂𝐏 𝐖𝐞𝐬𝐭 𝐕𝐢𝐫𝐠𝐢𝐧𝐢𝐚 𝐂𝐡𝐚𝐩𝐭𝐞𝐫 𝐌𝐞𝐞𝐭𝐢𝐧𝐠! We truly enjoyed meeting with laboratory professionals and discussing how our hematology and clinical chemistry systems help labs deliver reliable results every day.

We were delighted to welcome Mr. Ibrahim Parambil, General Manager of Biotech Medical, to our headquarters in Montpellie...
27/10/2025

We were delighted to welcome Mr. Ibrahim Parambil, General Manager of Biotech Medical, to our headquarters in Montpellier!

Biotech Medical is our official distributor in Qatar, and we’re excited to strengthen this recent partnership.

This collaboration marks an important step in expanding our presence in the region and delivering even more value to our customers.

Thank you, Mr. Parambil, for your visit — we look forward to a successful journey together!

𝐄𝐧𝐬𝐮𝐫𝐞 𝐚 𝐒𝐚𝐟𝐞 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐉𝐨𝐮𝐫𝐧𝐞𝐲 𝐰𝐢𝐭𝐡 𝐇𝐎𝐑𝐈𝐁𝐀HORIBA Companion Diagnostics Care offers tailored Hematology, Hemostasis, and ...
24/10/2025

𝐄𝐧𝐬𝐮𝐫𝐞 𝐚 𝐒𝐚𝐟𝐞 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐉𝐨𝐮𝐫𝐧𝐞𝐲 𝐰𝐢𝐭𝐡 𝐇𝐎𝐑𝐈𝐁𝐀
HORIBA Companion Diagnostics Care offers tailored Hematology, Hemostasis, and Clinical Chemistry solutions — designed to fit your lab and support safe, reliable decision-making.

📢 𝐒𝐩𝐞𝐜𝐢𝐚𝐥 𝐎𝐟𝐟𝐞𝐫: Combined Hematology, Hemostasis & Clinical Chemistry
Includes: PT, APTT, D-Dimer | CRP | 3 DIFF | DIFF, ESR, Malaria, Dengue | G6PD | Na⁺, K⁺, Cl⁻, Ca²⁺
(valid until December 15, 2025)

👉 Find the best combination for your lab — 𝐜𝐨𝐧𝐭𝐚𝐜𝐭 𝐮𝐬 𝐡𝐞𝐫𝐞 and benefit from our year-end offer: https://bit.ly/3WVT0Hb

Adresse

398 Rue Du Caducée
Grabels
34790

Heures d'ouverture

Lundi 09:00 - 18:00
Mardi 09:00 - 18:00
Mercredi 09:00 - 18:00
Jeudi 09:00 - 18:00
Vendredi 09:00 - 18:00

Téléphone

+33467141516

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Horiba for Healthcare publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Contacter La Pratique

Envoyer un message à Horiba for Healthcare:

Partager

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram